RETN and breast cancer: For this, we first transiently transfected BC cells with STAT3-specific (siSTAT3)- or non-targeted scrambled (NT-Scr) siRNAs for 24 h (in case of growth and clonogenicity assay) and 48 h (in case of motility and invasion assays) prior to rh-resistin treatment.